Answers are grounded in this paper and cite their sources.
Case report reveals heparin-induced thrombocytopenia in a postoperative orthopaedic patient receiving prophylactic low-molecular-weight heparin, highlighting risks of under-recognition.
Heparin is a drug widely used for thromboprophylaxis or treatment in many clinical situations. However, it can cause serious adverse effects, including thrombocytopenia, which is a potentially life-threatening condition. Unfortunately, heparin-induced thrombocytopenia is generally under-recognised and under-diagnosed. A case of heparin-induced thrombocytopenia occurring in a post-operative orthopaedic patient in association with prophylactic low-molecular-weight heparin is described.
No takes yet. Share an insight, caveat, or question.
Deepak Kejariwal (2006) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: